Sangamo Therapeutics Inc SGMO:NASDAQ

Last Price$11.35NASDAQ Previous Close - Last Trade as of 4:00PM ET 8/16/19

Today's Change0(0.00%)
Bid (Size)$10.95 (3)
Ask (Size)$11.84 (5)
Day Low / HighN/A - N/A
Volume1.3 M

View Biotechnology IndustryPeer Comparison as of 08/16/2019


Sangamo Therapeutics Inc ( NASDAQ )

Price: $11.35
Change: +0.30 (2.71%)
Volume: 1.3 M
4:00PM ET 8/16/2019

Coherus BioSciences Inc ( NASDAQ )

Price: $18.88
Change: +0.37 (2.00%)
Volume: 716.2 K
3:59PM ET 8/16/2019

AnaptysBio Inc ( NASDAQ )

Price: $49.20
Change: -0.79 (1.58%)
Volume: 327.7 K
4:00PM ET 8/16/2019

Editas Medicine Inc ( NASDAQ )

Price: $25.64
Change: +0.28 (1.10%)
Volume: 690.9 K
4:00PM ET 8/16/2019

Regenxbio Inc ( NASDAQ )

Price: $37.18
Change: +1.65 (4.64%)
Volume: 516.4 K
4:00PM ET 8/16/2019

Read more news Recent News

MT Newswires After-Hours News Movers
5:52PM ET 8/07/2019 MT Newswires

Some of the stocks moving on news-driven events in Wednesday's after-hours include: BKNG, +5.1% AVDR, +20.16% CVNA, +15.73% STMP, +15.52% SYMC, +12.93%...

Sangamo Therapeutics Q2 Loss Widens, Revenue Decreases But Tops Street Views
4:09PM ET 8/07/2019 MT Newswires

Sangamo Therapeutics (SGMO) reported a net loss of $0.26 per share in Q2, wider than the year-earlier loss of $0.17 a share but narrower than the loss of...

Close Update: US Stocks Slide as Strong US Jobs Report Dampens Investor Hopes for Steep Rate Cuts
4:19PM ET 7/08/2019 MT Newswires

Major stock indexes closed lower Monday as investor hopes for interest rate cuts at the end of July faded following June's strong employment report on...

Sector Update: Health Care Stocks Close Near Session Lows
4:03PM ET 7/08/2019 MT Newswires

Top Health Care Stocks JNJ +0.26% PFE -1.33% ABT -0.34% MRK -1.79% AMGN -1.98% Health care stocks retreated Monday, with the NYSE Health Care Index...

Company Profile

Business DescriptionSangamo Therapeutics, Inc. engages in researching and developing transcription factors in the regulation of genes. It focuses on the research, development and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation technology platform is enabled by the engineering of a class of transcription factors known as zinc finger DNA-binding proteins. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Richmond, CA. View company web site for more details
AddressPoint Richmond Tech Center II
Richmond, California 94804
Number of Employees302
Recent SEC Filing08/14/20194
President, Chief Executive Officer & DirectorAlexander D. Macrae
Chief Financial Officer, EVP-Corporate StrategySt├ęphane Boissel
Chief Technology Officer & Senior Vice PresidentEdward J. Rebar
Executive Vice President & General CounselGary H. Loeb

Company Highlights

Price Open$11.13
Previous Close$11.05
52 Week Range$6.26 - 19.25
Market Capitalization$1.3 B
Shares Outstanding115.7 M
SectorHealth Technology
Next Earnings Announcement11/14/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.99
Beta vs. S&P 500N/A
Revenue$84.5 M
Net Profit Margin-136.73%
Return on Equity-27.35%

Analyst Ratings as of 08/09/2019

Consensus RecommendationConsensus Icon
Powered by Factset